1. Home
  2. GILT vs SCPH Comparison

GILT vs SCPH Comparison

Compare GILT & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • SCPH
  • Stock Information
  • Founded
  • GILT 1987
  • SCPH 2013
  • Country
  • GILT Israel
  • SCPH United States
  • Employees
  • GILT N/A
  • SCPH N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GILT Technology
  • SCPH Health Care
  • Exchange
  • GILT Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • GILT 604.7M
  • SCPH 299.0M
  • IPO Year
  • GILT 1993
  • SCPH 2017
  • Fundamental
  • Price
  • GILT $11.34
  • SCPH $5.64
  • Analyst Decision
  • GILT Strong Buy
  • SCPH Buy
  • Analyst Count
  • GILT 2
  • SCPH 3
  • Target Price
  • GILT $11.00
  • SCPH $12.00
  • AVG Volume (30 Days)
  • GILT 857.5K
  • SCPH 2.3M
  • Earning Date
  • GILT 11-12-2025
  • SCPH 11-12-2025
  • Dividend Yield
  • GILT N/A
  • SCPH N/A
  • EPS Growth
  • GILT 12.49
  • SCPH N/A
  • EPS
  • GILT 0.39
  • SCPH N/A
  • Revenue
  • GILT $349,746,000.00
  • SCPH $49,969,000.00
  • Revenue This Year
  • GILT $47.18
  • SCPH $108.95
  • Revenue Next Year
  • GILT $13.80
  • SCPH $78.30
  • P/E Ratio
  • GILT $27.54
  • SCPH N/A
  • Revenue Growth
  • GILT 19.67
  • SCPH 107.79
  • 52 Week Low
  • GILT $4.54
  • SCPH $1.94
  • 52 Week High
  • GILT $11.59
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • GILT 72.36
  • SCPH 64.10
  • Support Level
  • GILT $9.95
  • SCPH $4.33
  • Resistance Level
  • GILT $11.60
  • SCPH $5.62
  • Average True Range (ATR)
  • GILT 0.39
  • SCPH 0.04
  • MACD
  • GILT 0.11
  • SCPH -0.00
  • Stochastic Oscillator
  • GILT 88.40
  • SCPH 93.10

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Share on Social Networks: